These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of dopamine and norepinephrine in shock. Romero CM. N Engl J Med; 2010 Jun 17; 362(24):2328; author reply 2330-1. PubMed ID: 20554990 [No Abstract] [Full Text] [Related]
6. Comparison of dopamine and norepinephrine in the treatment of shock. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II Investigators. N Engl J Med; 2010 Mar 04; 362(9):779-89. PubMed ID: 20200382 [Abstract] [Full Text] [Related]
14. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock. Bartel B. S D Med; 2014 May 04; 67(5):200-1. PubMed ID: 24851468 [No Abstract] [Full Text] [Related]
15. Vasoactive drug support in septic shock. Dries DJ. Shock; 2006 Nov 04; 26(5):529-30. PubMed ID: 17047528 [No Abstract] [Full Text] [Related]
16. [Norepinephrine-new milestone for treatment of shock]. Wu LJ. Zhonghua Yi Xue Za Zhi; 2011 Jul 19; 91(27):1873-4. PubMed ID: 22093838 [No Abstract] [Full Text] [Related]
17. Recommendations for the treatment of patients with septic shock. Meier-Hellmann A, Reinhart K. Acta Anaesthesiol Scand Suppl; 1997 Jul 19; 111():177-80. PubMed ID: 9421002 [No Abstract] [Full Text] [Related]
18. Pharmacologic interventions in resuscitation. Boike SC, Rybak MJ. Emerg Med Clin North Am; 1983 Dec 19; 1(3):553-69. PubMed ID: 6396072 [Abstract] [Full Text] [Related]
19. Arginine vasopressin in vasodilatory shock. Fuchs FD, Filho JW. Circulation; 2003 Nov 11; 108(19):e141; author reply e141. PubMed ID: 14610004 [No Abstract] [Full Text] [Related]
20. Medical aspects of shock. I. The effects of vasopressor agents in shock. Moyer JH, Mills LC. R I Med J; 1966 Jan 11; 49(1):28-36. PubMed ID: 5216149 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]